Costs associated with influenza-related hospitalization in the elderly.
Identifieur interne : 000102 ( Main/Exploration ); précédent : 000101; suivant : 000103Costs associated with influenza-related hospitalization in the elderly.
Auteurs : Núria Torner [Espagne] ; Encarna Navas [Espagne] ; Núria Soldevila [Espagne] ; Diana Toledo [Espagne] ; Gemma Navarro [Espagne] ; Aurea Morillo [Espagne] ; Maria José Pérez [Espagne] ; Angela Domínguez [Espagne]Source :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- economics : Hospitalization, Influenza, Human.
- Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Health Care Costs, Humans, Male, Spain.
Abstract
Seasonal influenza epidemics remain a considerable burden in adults, especially in those at higher risk of complications. The aim of this study was to determine the costs associated with influenza-related hospitalization in patients aged ≥65 y admitted to 20 hospitals from 7 Spanish regions during the 2013-14 and 2014-15 influenza seasons. Bivariate analysis was used to compare costs in vaccinated and unvaccinated cases. Costs were calculated according to the Spanish National Health System diagnosis-related group tables for influenza and other respiratory system conditions (GRD 89 and GRD 101). A total of 728 confirmed influenza cases were recorded: 52.9% were male, 46.7% were aged 75-84 years, and 49.3% received influenza vaccine ≥15 d prior to hospital admission. Influenza-related mean hospitalization costs (MHC) were € 1,184,808 in unvaccinated and € 1,152,333 in vaccinated cases (2.75% lower). Influenza vaccination showed significant protection against ICU admission (OR 0.35, 95%CI 0.21-0.59; p < 0001); mechanical ventilation (OR 0.56, 95%CI 0.39-0.80; p = 0.002); secondary bacterial pneumonia (OR 0.61, 95%CI 0.39-0.98; p = 0.04) and a higher degree of dependence (OR 0.74, 95%CI 0.55-0.99; p = 0.04). No association was observed for the Charlson comorbidity index or the mean hospital stay. Although influenza vaccination of the elderly may not achieve significant savings in mean hospitalization costs, it may lessen the degree of severity and avoid complications.
DOI: 10.1080/21645515.2017.1264829
PubMed: 27925855
PubMed Central: PMC5328227
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Costs associated with influenza-related hospitalization in the elderly.</title><author><name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>c Public Health Agency of Catalonia , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Navas, Encarna" sort="Navas, Encarna" uniqKey="Navas E" first="Encarna" last="Navas">Encarna Navas</name><affiliation wicri:level="1"><nlm:affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>c Public Health Agency of Catalonia , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation></author><author><name sortKey="Toledo, Diana" sort="Toledo, Diana" uniqKey="Toledo D" first="Diana" last="Toledo">Diana Toledo</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation></author><author><name sortKey="Navarro, Gemma" sort="Navarro, Gemma" uniqKey="Navarro G" first="Gemma" last="Navarro">Gemma Navarro</name><affiliation wicri:level="1"><nlm:affiliation>d Epidemiology Unit , Corporació Sanitària i Universitaria Parc Taulí , Sabadell , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>d Epidemiology Unit , Corporació Sanitària i Universitaria Parc Taulí , Sabadell </wicri:regionArea><wicri:noRegion>Sabadell </wicri:noRegion></affiliation></author><author><name sortKey="Morillo, Aurea" sort="Morillo, Aurea" uniqKey="Morillo A" first="Aurea" last="Morillo">Aurea Morillo</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>e Preventive Medicine and Public Health Department , University Hospital Virgen del Rocio , Seville , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>e Preventive Medicine and Public Health Department , University Hospital Virgen del Rocio , Seville </wicri:regionArea><wicri:noRegion>Seville </wicri:noRegion></affiliation></author><author><name sortKey="Perez, Maria Jose" sort="Perez, Maria Jose" uniqKey="Perez M" first="Maria José" last="Pérez">Maria José Pérez</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>f Preventive Medicine and Public Health Department , University Hospital of Valme , Seville , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>f Preventive Medicine and Public Health Department , University Hospital of Valme , Seville </wicri:regionArea><wicri:noRegion>Seville </wicri:noRegion></affiliation></author><author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Domínguez">Angela Domínguez</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27925855</idno><idno type="pmid">27925855</idno><idno type="doi">10.1080/21645515.2017.1264829</idno><idno type="pmc">PMC5328227</idno><idno type="wicri:Area/Main/Corpus">00104</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00104</idno><idno type="wicri:Area/Main/Curation">000104</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000104</idno><idno type="wicri:Area/Main/Exploration">000104</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Costs associated with influenza-related hospitalization in the elderly.</title><author><name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>c Public Health Agency of Catalonia , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Navas, Encarna" sort="Navas, Encarna" uniqKey="Navas E" first="Encarna" last="Navas">Encarna Navas</name><affiliation wicri:level="1"><nlm:affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>c Public Health Agency of Catalonia , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation></author><author><name sortKey="Toledo, Diana" sort="Toledo, Diana" uniqKey="Toledo D" first="Diana" last="Toledo">Diana Toledo</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation></author><author><name sortKey="Navarro, Gemma" sort="Navarro, Gemma" uniqKey="Navarro G" first="Gemma" last="Navarro">Gemma Navarro</name><affiliation wicri:level="1"><nlm:affiliation>d Epidemiology Unit , Corporació Sanitària i Universitaria Parc Taulí , Sabadell , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>d Epidemiology Unit , Corporació Sanitària i Universitaria Parc Taulí , Sabadell </wicri:regionArea><wicri:noRegion>Sabadell </wicri:noRegion></affiliation></author><author><name sortKey="Morillo, Aurea" sort="Morillo, Aurea" uniqKey="Morillo A" first="Aurea" last="Morillo">Aurea Morillo</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>e Preventive Medicine and Public Health Department , University Hospital Virgen del Rocio , Seville , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>e Preventive Medicine and Public Health Department , University Hospital Virgen del Rocio , Seville </wicri:regionArea><wicri:noRegion>Seville </wicri:noRegion></affiliation></author><author><name sortKey="Perez, Maria Jose" sort="Perez, Maria Jose" uniqKey="Perez M" first="Maria José" last="Pérez">Maria José Pérez</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>f Preventive Medicine and Public Health Department , University Hospital of Valme , Seville , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>f Preventive Medicine and Public Health Department , University Hospital of Valme , Seville </wicri:regionArea><wicri:noRegion>Seville </wicri:noRegion></affiliation></author><author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Domínguez">Angela Domínguez</name><affiliation wicri:level="1"><nlm:affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid </wicri:regionArea><wicri:noRegion>Madrid </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Female (MeSH)</term><term>Health Care Costs (MeSH)</term><term>Hospitalization (economics)</term><term>Humans (MeSH)</term><term>Influenza, Human (economics)</term><term>Male (MeSH)</term><term>Spain (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Coûts des soins de santé (MeSH)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (économie)</term><term>Hospitalisation (économie)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Hospitalization</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Grippe humaine</term><term>Hospitalisation</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Care Costs</term><term>Humans</term><term>Male</term><term>Spain</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Coûts des soins de santé</term><term>Espagne</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Seasonal influenza epidemics remain a considerable burden in adults, especially in those at higher risk of complications. The aim of this study was to determine the costs associated with influenza-related hospitalization in patients aged ≥65 y admitted to 20 hospitals from 7 Spanish regions during the 2013-14 and 2014-15 influenza seasons. Bivariate analysis was used to compare costs in vaccinated and unvaccinated cases. Costs were calculated according to the Spanish National Health System diagnosis-related group tables for influenza and other respiratory system conditions (GRD 89 and GRD 101). A total of 728 confirmed influenza cases were recorded: 52.9% were male, 46.7% were aged 75-84 years, and 49.3% received influenza vaccine ≥15 d prior to hospital admission. Influenza-related mean hospitalization costs (MHC) were € 1,184,808 in unvaccinated and € 1,152,333 in vaccinated cases (2.75% lower). Influenza vaccination showed significant protection against ICU admission (OR 0.35, 95%CI 0.21-0.59; p < 0001); mechanical ventilation (OR 0.56, 95%CI 0.39-0.80; p = 0.002); secondary bacterial pneumonia (OR 0.61, 95%CI 0.39-0.98; p = 0.04) and a higher degree of dependence (OR 0.74, 95%CI 0.55-0.99; p = 0.04). No association was observed for the Charlson comorbidity index or the mean hospital stay. Although influenza vaccination of the elderly may not achieve significant savings in mean hospitalization costs, it may lessen the degree of severity and avoid complications.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27925855</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>02</Month></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Costs associated with influenza-related hospitalization in the elderly.</ArticleTitle><Pagination><MedlinePgn>412-416</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2017.1264829</ELocationID><Abstract><AbstractText>Seasonal influenza epidemics remain a considerable burden in adults, especially in those at higher risk of complications. The aim of this study was to determine the costs associated with influenza-related hospitalization in patients aged ≥65 y admitted to 20 hospitals from 7 Spanish regions during the 2013-14 and 2014-15 influenza seasons. Bivariate analysis was used to compare costs in vaccinated and unvaccinated cases. Costs were calculated according to the Spanish National Health System diagnosis-related group tables for influenza and other respiratory system conditions (GRD 89 and GRD 101). A total of 728 confirmed influenza cases were recorded: 52.9% were male, 46.7% were aged 75-84 years, and 49.3% received influenza vaccine ≥15 d prior to hospital admission. Influenza-related mean hospitalization costs (MHC) were € 1,184,808 in unvaccinated and € 1,152,333 in vaccinated cases (2.75% lower). Influenza vaccination showed significant protection against ICU admission (OR 0.35, 95%CI 0.21-0.59; p < 0001); mechanical ventilation (OR 0.56, 95%CI 0.39-0.80; p = 0.002); secondary bacterial pneumonia (OR 0.61, 95%CI 0.39-0.98; p = 0.04) and a higher degree of dependence (OR 0.74, 95%CI 0.55-0.99; p = 0.04). No association was observed for the Charlson comorbidity index or the mean hospital stay. Although influenza vaccination of the elderly may not achieve significant savings in mean hospitalization costs, it may lessen the degree of severity and avoid complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torner</LastName><ForeName>Núria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navas</LastName><ForeName>Encarna</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>c Public Health Agency of Catalonia , Barcelona , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soldevila</LastName><ForeName>Núria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledo</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>d Epidemiology Unit , Corporació Sanitària i Universitaria Parc Taulí , Sabadell , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillo</LastName><ForeName>Aurea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>e Preventive Medicine and Public Health Department , University Hospital Virgen del Rocio , Seville , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez</LastName><ForeName>Maria José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>f Preventive Medicine and Public Health Department , University Hospital of Valme , Seville , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domínguez</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III , Madrid , Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Medicine , Public Health Unit. University of Barcelona , Barcelona , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Working Group of the Project PI12/02079</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Influenza</Keyword><Keyword MajorTopicYN="Y">cost</Keyword><Keyword MajorTopicYN="Y">elderly</Keyword><Keyword MajorTopicYN="Y">hospitalization</Keyword><Keyword MajorTopicYN="Y">immunization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27925855</ArticleId><ArticleId IdType="doi">10.1080/21645515.2017.1264829</ArticleId><ArticleId IdType="pmc">PMC5328227</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Euro Surveill. 2015 Feb 26;20(8):null</Citation><ArticleIdList><ArticleId IdType="pubmed">25742432</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 May 03;17(18):null</Citation><ArticleIdList><ArticleId IdType="pubmed">22587958</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 Dec 2;23(3):283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15530669</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2016;15(3):425-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26690376</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Oct 4;357(14):1373-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17914038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2014;10(2):428-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24165394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chronic Dis. 1987;40(5):373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2010 Mar 20;2:RRN1153</Citation><ArticleIdList><ArticleId IdType="pubmed">20352125</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jun 19;9(6):e100497</Citation><ArticleIdList><ArticleId IdType="pubmed">24945510</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2016 Feb 24;16:185</Citation><ArticleIdList><ArticleId IdType="pubmed">26911615</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2010 Nov 24;10:724</Citation><ArticleIdList><ArticleId IdType="pubmed">21106057</ArticleId></ArticleIdList></Reference><Reference><Citation>Md State Med J. 1965 Feb;14:61-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):324-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22967458</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2012 Nov;23(6):839-42; discussion 843-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23038110</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2000 Nov;19(11):834-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11152308</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2002 Dec 20;20 Suppl 5:B50-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12477420</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Poverty. 2015 Oct 06;4:44</Citation><ArticleIdList><ArticleId IdType="pubmed">26445412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2000 Mar;181(3):831-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10720501</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 May 22;8(5):e63788</Citation><ArticleIdList><ArticleId IdType="pubmed">23717485</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2016 Jun 2;20(22):</Citation><ArticleIdList><ArticleId IdType="pubmed">27277013</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jul 31;10(7):e0132922</Citation><ArticleIdList><ArticleId IdType="pubmed">26230271</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1998 Sep 14;158(16):1769-76</Citation><ArticleIdList><ArticleId IdType="pubmed">9738606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Aug 24;30(39):5714-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22819720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Mar;8(3):328-35</Citation><ArticleIdList><ArticleId IdType="pubmed">22327498</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Ther. 2015 Dec;4(4):459-87</Citation><ArticleIdList><ArticleId IdType="pubmed">26350238</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Jan 15;25(5):846-55</Citation><ArticleIdList><ArticleId IdType="pubmed">17074423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Jan;8(1):21-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22252007</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name></noRegion><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Domínguez">Angela Domínguez</name><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Angela" last="Domínguez">Angela Domínguez</name><name sortKey="Morillo, Aurea" sort="Morillo, Aurea" uniqKey="Morillo A" first="Aurea" last="Morillo">Aurea Morillo</name><name sortKey="Morillo, Aurea" sort="Morillo, Aurea" uniqKey="Morillo A" first="Aurea" last="Morillo">Aurea Morillo</name><name sortKey="Navarro, Gemma" sort="Navarro, Gemma" uniqKey="Navarro G" first="Gemma" last="Navarro">Gemma Navarro</name><name sortKey="Navas, Encarna" sort="Navas, Encarna" uniqKey="Navas E" first="Encarna" last="Navas">Encarna Navas</name><name sortKey="Perez, Maria Jose" sort="Perez, Maria Jose" uniqKey="Perez M" first="Maria José" last="Pérez">Maria José Pérez</name><name sortKey="Perez, Maria Jose" sort="Perez, Maria Jose" uniqKey="Perez M" first="Maria José" last="Pérez">Maria José Pérez</name><name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name><name sortKey="Toledo, Diana" sort="Toledo, Diana" uniqKey="Toledo D" first="Diana" last="Toledo">Diana Toledo</name><name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name><name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000102 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000102 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27925855
|texte= Costs associated with influenza-related hospitalization in the elderly.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27925855" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |